Jiangsu Rijiu Optoelectronics Jointstock (003015)
Search documents
日久光电(003015) - 上海君澜律师事务所关于江苏日久光电股份有限公司2025年员工持股计划(草案)之法律意见书
2025-04-14 13:04
二〇二五年四月 上海君澜律师事务所 关于 江苏日久光电股份有限公司 2025 年员工持股计划(草案) 之 法律意见书 上海君澜律师事务所 法律意见书 上海君澜律师事务所 关于江苏日久光电股份有限公司 2025 年员工持股计划(草案)之 法律意见书 致:江苏日久光电股份有限公司 上海君澜律师事务所(以下简称"本所")接受江苏日久光电股份有限公 司(以下简称"日久光电"或"公司")的委托,根据《中华人民共和国公司 法》《中华人民共和国证券法》《关于上市公司实施员工持股计划试点的指导 意见》(以下简称"《试点指导意见》")、《深圳证券交易所上市公司自律 监管指引第 1 号——主板上市公司规范运作》(以下简称"《监管指引》") 及《江苏日久光电股份有限公司章程》(以下简称"《公司章程》")等相关 规定,就《江苏日久光电股份有限公司 2025 年员工持股计划(草案)》(以下 简称"本次员工持股计划"或"《员工持股计划(草案)》")的相关事项出 具本法律意见书。 对本法律意见书,本所律师声明如下: (一)本所律师依据《中华人民共和国证券法》《律师事务所从事证券法 律业务管理办法》和《律师事务所证券法律业务执业规则(试行) ...
日久光电(003015) - 江苏日久光电股份有限公司2025年员工持股计划管理办法
2025-04-14 13:03
江苏日久光电股份有限公司 2025 年员工持股计划管理办法 二〇二五年四月 1 第一章 总则 第一条 为规范江苏日久光电股份有限公司(以下简称"日久光电"或"公 司")2025 年员工持股计划(以下简称"员工持股计划"、"本员工持股计划") 的实施,根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共 和国证券法》(以下简称"《证券法》")、《关于上市公司实施员工持股计划试点的 指导意见》(以下简称"《指导意见》")、《深圳证券交易所上市公司自律监管指引 第 1 号——主板上市公司规范运作》(以下简称"《自律监管指引》")等相关法律、 行政法规、规章、规范性文件和《公司章程》之规定,特制定本管理办法。 第二章 员工持股计划的制定 第二条 员工持股计划所遵循的基本原则 (一)依法合规原则 公司实施本员工持股计划,严格按照法律、行政法规的规定履行程序,真实、 准确、完整、及时地实施信息披露。任何人不得利用本员工持股计划进行内幕交 易、操纵证券市场等证券欺诈行为。 (二)自愿参与原则 公司实施本员工持股计划遵循公司自主决定,员工自愿参加的原则,公司不 以摊派、强行分配等方式强制员工参加本员工持股计划 ...
日久光电2024年扭亏为盈:调光导电膜营收翻倍增长 光学膜业务成新亮点
Quan Jing Wang· 2025-04-14 11:19
Core Insights - The company reported a revenue of 583 million yuan for 2024, marking a year-on-year growth of 22%, and achieved a net profit of 67.47 million yuan, successfully turning around from a loss [1] - The significant growth in performance is driven by the explosive growth of the dimming conductive film and optical film businesses, with both product lines experiencing revenue increases exceeding 100% year-on-year, becoming key engines for the company's transformation and upgrade [1] Revenue Breakdown - The dimming conductive film business generated a revenue of 66.95 million yuan, reflecting a substantial year-on-year increase of 122.70% [1] - The optical film products achieved a revenue of 29.45 million yuan, with a year-on-year growth of 104.19% [1] Market Position and Strategy - The company holds a 52% global market share in ITO conductive films and has made technological breakthroughs in optical films, establishing a dual-track layout covering consumer electronics and new energy vehicles [2] - In 2024, the company's R&D investment accounted for 5.80% of its revenue, focusing on core technologies such as magnetron sputtering and precision coating to continuously optimize product structure [2] Future Outlook - The company plans to expand the application of dimming conductive films in the new energy vehicle sector and accelerate the industrialization of optical films in vehicle displays and foldable screens [2] - With an increasing proportion of high-value-added products, the company's profitability and market competitiveness are expected to strengthen further [2]
4月14日晚间重要公告一览
Xi Niu Cai Jing· 2025-04-14 10:39
Group 1 - Company Instech reported a net profit of 177 million yuan for 2024, a year-on-year increase of 28.15%, with a proposed cash dividend of 1.20 yuan per 10 shares [1] - Instech achieved an operating revenue of 1.185 billion yuan in 2024, representing a year-on-year growth of 24.45% [1] - The company specializes in the research, production, and sales of rare earth permanent magnet materials and applications [2] Group 2 - Company Junda reported a net loss of 106 million yuan for Q1 2025, transitioning from profit to loss, with a year-on-year revenue decline of 49.52% [3] - Junda's operating revenue for Q1 2025 was 1.875 billion yuan [3] - The company focuses on the research, production, and sales of photovoltaic cell products [4] Group 3 - Company Annada reported a net loss of 10.26 million yuan for Q1 2025, with a year-on-year revenue increase of 1.44% [5] - Annada's operating revenue for Q1 2025 was 473 million yuan [5] - The company specializes in titanium dioxide and iron phosphate products [6] Group 4 - Company Jiuzhou Pharmaceutical reported a net profit of 250 million yuan for Q1 2025, a year-on-year increase of 5.68% [7] - Jiuzhou's operating revenue for Q1 2025 was 1.49 billion yuan, reflecting a year-on-year growth of 0.98% [7] - The company provides custom research and production services for pharmaceutical companies and research institutions [8] Group 5 - Company Yitong Century won a 1.48 billion yuan contract for a 5G comprehensive maintenance project with Guangdong Unicom [9] - The project will enhance the company's business volume and expansion in Guangdong [9] - Yitong Century specializes in communication network technology services and solutions [10] Group 6 - Company Rijiu Optoelectronics reported a net profit of 67.47 million yuan for 2024, a year-on-year increase of 506.9%, with a proposed cash dividend of 2.00 yuan per 10 shares [10] - Rijiu's operating revenue for 2024 was 583 million yuan, representing a year-on-year growth of 22% [10] - The company focuses on the research, production, and sales of touch display application materials [11] Group 7 - Company Ruotong reported a net profit of 95.98 million yuan for 2024, a year-on-year increase of 0.91%, with a proposed cash dividend of 2.00 yuan per 10 shares [12] - Ruotong's operating revenue for 2024 was 408 million yuan, reflecting a year-on-year growth of 7.54% [12] - The company specializes in drilling and completion equipment for oil and gas [13] Group 8 - Company Shuangxiang reported a net profit of 472 million yuan for 2024, a year-on-year increase of 754.84%, with a proposed cash dividend of 1.50 yuan per 10 shares [14] - Shuangxiang's operating revenue for 2024 was 2.29 billion yuan, representing a year-on-year growth of 51.55% [14] - The company focuses on synthetic leather and optical-grade PMMA products [15] Group 9 - Company Xinfang Pharmaceutical reported a net profit of 101 million yuan for 2024, a year-on-year decrease of 64.70%, with a proposed cash dividend of 0.30 yuan per 10 shares [16] - Xinfang's operating revenue for 2024 was 6.032 billion yuan, reflecting a year-on-year decline of 6.63% [16] - The company is involved in medical services, pharmaceutical distribution, and manufacturing [17] Group 10 - Company Dongxing Medical reported a net profit of 97.42 million yuan for 2024, a year-on-year increase of 0.21%, with a proposed cash dividend of 6.00 yuan per 10 shares [18] - Dongxing's operating revenue for 2024 was 435 million yuan, reflecting a year-on-year growth of 0.40% [18] - The company specializes in surgical medical devices [19] Group 11 - Company Wuzhou Special Paper reported a net profit of 64.68 million yuan for Q1 2025, a year-on-year decrease of 51.56%, with an operating revenue of 1.989 billion yuan [20] - Wuzhou's operating revenue for Q1 2025 increased by 15.21% [20] - The company focuses on the research, production, and sales of mechanism paper and pulp [21] Group 12 - Company Jinrui Mining expects a net profit of 15.28 million yuan for Q1 2025, a year-on-year increase of 617.40% [22] - The company specializes in the production and sales of strontium salt products [23] Group 13 - Company Youyan New Materials expects a net profit of 60 million to 75 million yuan for Q1 2025, a year-on-year increase of 13076% to 16370% [24] - The company focuses on electronic films, precious metal materials, and rare earth materials [25] Group 14 - Company Guoli expects a net profit of 11 million to 13 million yuan for Q1 2025, a year-on-year increase of 164.38% to 212.45% [26] - The company specializes in urban infrastructure design, construction, and investment [27] Group 15 - Company Shenzhen Airport reported a passenger throughput of 5.5422 million in March, a year-on-year increase of 8.70% [28] - The airport's cargo throughput was 171,900 tons, reflecting a year-on-year growth of 14.51% [28] - The company is involved in aviation and related non-aviation businesses [29] Group 16 - Company Shenghui Integration reported an order balance of 2.117 billion yuan as of March 31, 2025, a year-on-year increase of 11.89% [30] - The company provides cleanroom engineering and electromechanical engineering services [31] Group 17 - Company Chengyi Pharmaceutical received a drug registration certificate for Mercaptopurine tablets [32] - The drug is applicable for various diseases including choriocarcinoma and acute lymphoblastic leukemia [32] Group 18 - Company Enhua Pharmaceutical initiated Phase I clinical trials for NH280105 capsules, targeting Alzheimer's disease [33] - The trial aims to assess the safety and pharmacokinetics of the drug [33] Group 19 - Company Lingang Steel proposed a share buyback of 50 million to 100 million yuan [34] - The company specializes in the production and development of metallurgical products [35] Group 20 - Company Fujia plans to repurchase shares worth 15 million to 30 million yuan [36] - The company focuses on smart cleaning appliances and key components [37] Group 21 - Company Mould Technology received a project designation letter for exterior parts from a luxury car client, with an estimated total sales of 2.07 billion yuan [38] - The project is expected to start mass production in April 2027 [38] Group 22 - Company Longxin General expects a net profit of 4.55 billion to 5.30 billion yuan for Q1 2025, a year-on-year increase of 76.65% to 105.77% [39] - The company specializes in motorcycles, engines, and general machinery products [40] Group 23 - Company Dongfang Securities reported a net profit of 1.436 billion yuan for Q1 2025, a year-on-year increase of 62.08% [41] - The company focuses on investment management and securities trading [42] Group 24 - Company Yalian Machinery plans to use up to 800 million yuan of idle funds for low-risk financial products [43] - The company specializes in the production of engineered wood production lines and equipment [44] Group 25 - Company Guanghua Technology reported a net loss of 205 million yuan for 2024, with total revenue of 2.589 billion yuan [45] - The company focuses on PCB chemicals and lithium battery materials [46] Group 26 - Company Boya Biotechnology plans to publicly transfer 80% of its subsidiary's equity for 213 million yuan [47] - The transaction aims to optimize resource allocation focusing on blood products [48] Group 27 - Company Darui Electronics plans to repurchase shares worth 30 million to 50 million yuan [49] - The company specializes in customized components and automation equipment [50] Group 28 - Company Hongying Intelligent plans to repurchase shares worth 30 million to 40 million yuan [51] - The company focuses on smart control products and assemblies [52] Group 29 - Company Guangku Technology announced a change in the upper shareholding structure of its controlling shareholder [53] - The operational activities of the company will not be materially affected [54] Group 30 - Company Dingjie Smart's application for convertible bond issuance has been accepted by the Shenzhen Stock Exchange [55] - The company provides digital and intelligent solutions for various industries [56]
日久光电(003015) - 年度关联方资金占用专项审计报告
2025-04-14 08:45
容诚会计师事务所(特殊普通合伙) ิธรัส | 容诚 非经营性资金占用及其他关联资金 往来情况专项说明 江苏日久光电股份有限公司 容诚专字[2025]215Z0083号 江苏日久光电股份有限公司全体股东: 中国 · 北京 : 服会计机 关于江苏日久光电股份有限公司 非经营性资金占用及其他关联资金往来情况专项说明 容诚专字[2025]215Z0083号 我们对汇总表所载信息与本所审计日久光电 2024 年度财务报表时所复核的会 计资料和经审计的财务报表的相关内容进行了核对,在所有重大方面没有发现不 一致。除了对日久光电实施 2024年度财务报表审计中所执行的对关联方交易有关 的审计程序外,我们并未对汇总表所载资料执行额外的审计程序。为了更好地理 解日久光电的非经营性资金占用及其他关联资金往来情况,后附汇总表应当与已 审计的财务报表一并阅读。 本专项说明仅供日久光电年度报告披露之目的使用,不得用作任何其他目的。 附件:江苏日久光电股份有限公司 2024年度非经营性资金占用及其他关联资 金往来情况汇总表。 我们接受委托,依据中国注册会计师审计准则审计了江苏日久光电股份有限 公司(以下简称"日久光电")2024年1 ...
日久光电(003015) - 内部控制审计报告
2025-04-14 08:45
"假M 容诚 内部控制审计报告 江苏日久光电股份有限公司 容诚审字|2025|215Z0192号 容诚会计师事务所(特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://acc.mof.gov.cn)"进行查 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://acc.jpgv.cn)"进行查 内部控制审计报告 容诚审字[2025]215Z0192号 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是日久 光电董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于 情况的变化可能导致内部控制变得不恰当,或对控制政策和程序遵循的程度降低, 根据内部控制审计结果推测未来内部控制的有效性具有一定风险。 四、财务报告内部控制审计意见 我们 ...
日久光电(003015) - 2024年年度审计报告
2025-04-14 08:45
RSM | 容 诚 审计报告 江苏日久光电股份有限公司 容诚审字[2025]215Z0191号 容诚会计师事务所 (特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://zgzc.mof.gov.cn)"进行全 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http:/// z 报告编码:京25WLXdKX 录 | 序号 | 内 容 | 项码 | | --- | --- | --- | | 1 | 审计报告 | 1-7 | | 2 | 合并资产负债表 | 1 | | 3 | 合并利润表 | 2 | | 4 | 合并现金流量表 | 3 | | 5 | 合并所有者权益变动表 | 4 - 5 | | 6 | 母公司资产负债表 | 6 | | 7 | 母公司利润表 | 7 | | 8 | 母公司现金流量表 | 8 | | 9 | 母公司所有者权益变动表 | 9 - 10 | | 10 | 财务报表附注 | 11 - 116 | 审 计 报 告 容诚审字[2025]215Z0191号 江苏日久光电股份有限公司全体股东: 一、审计意见 我们审计了江苏日久光电股 ...
日久光电(003015) - 2024年度独立董事述职报告(任永平)
2025-04-14 08:45
江苏日久光电股份有限公司 2024 年度独立董事述职报告 作为江苏日久光电股份有限公司(以下简称"日久光电"或"公司")的独 立董事,本人严格按照《公司法》《证券法》《上市公司独立董事管理办法》等 法律法规及《公司章程》的规定,恪尽职守、勤勉履行职务,积极出席相关会议, 认真审议董事会各项议案,充分发挥独立董事及各专门委员会的作用,维护公司 及全体股东的利益。现将 2024 年度履行独立董事职责的情况报告如下: 一、基本情况 (一)工作履历、专业背景及兼职情况 任永平先生,中国国籍,无境外永久居留权。1963 年出生,会计学博士研 究生。曾任江苏大学教授、财务处副处长、上海大学管理学院党委书记、副院长; 现任上海大学教授、MBA 中心学术主任;2020 年 12 月至今任江苏日久光电股份 有限公司独立董事,同时担任光大证券股份有限公司独立董事、江苏扬农化工股 份有限公司独立董事。 (二)独立性情况 (一)出席董事会、股东大会情况 2024 年度,公司共计召开 7 次董事会,以现场投票与网络投票相结合的方式 召开股东大会 2 次。公司董事会、股东大会的召集召开符合法定程序。2024 年 度具体出席董事会、股东大 ...
日久光电(003015) - 2024年度独立董事述职报告(张雅)
2025-04-14 08:45
江苏日久光电股份有限公司 2024 年度独立董事述职报告 作为江苏日久光电股份有限公司(以下简称"日久光电"或"公司")的独 立董事,本人严格按照《公司法》《证券法》《上市公司独立董事管理办法》等 法律法规及《公司章程》的规定,恪尽职守、勤勉履行职务,积极出席相关会议, 认真审议董事会各项议案,充分发挥独立董事及各专门委员会的作用,维护公司 及全体股东的利益。现将 2024 年度履行独立董事职责的情况报告如下: 一、基本情况 (一)工作履历、专业背景及兼职情况 张雅先生,中国国籍,无境外永久居留权。1981 年出生,法律学士学历。 曾任中共太仓市纪律检查委员会、太仓市监察局纪检监察室科员、江苏太仓港口 管理委员会港政局科员、江苏金太律师事务所实习律师、江苏金太律师事务所律 师、上海君澜律师事务所律师、北京市中银(上海)律师事务所律师;现任北京 浩天(上海)律师事务所律师;2020 年 12 月至今任江苏日久光电股份有限公司 独立董事,同时担任南通冠优达磁业股份有限公司(非上市公司)独立董事。 (二)独立性情况 报告期内,作为公司的独立董事,本人未在公司担任除独立董事以外的任何 职务,本人及直系亲属、主要社会关 ...
日久光电(003015) - 2024年度独立董事述职报告(孔烽)
2025-04-14 08:45
2024 年度独立董事述职报告 作为江苏日久光电股份有限公司(以下简称"日久光电"或"公司")的独 立董事,本人严格按照《公司法》《证券法》《上市公司独立董事管理办法》等 法律法规及《公司章程》的规定,恪尽职守、勤勉履行职务,积极出席相关会议, 认真审议董事会各项议案,充分发挥独立董事及各专门委员会的作用,维护公司 及全体股东的利益。现将 2024 年度履行独立董事职责的情况报告如下: 一、基本情况 (一)工作履历、专业背景及兼职情况 孔烽先生,中国国籍,无境外永久居留权。1976 年出生,硕士学历。曾任 汤臣集团嘉地房地产开发有限公司会计、三固房地产咨询(上海)有限公司财务 经理、博维康迅信息科技发展有限公司财务总监、麦迪斯顿(北京)医疗科技有 限公司财务总监、苏州麦迪斯顿医疗科技有限公司财务总监、董秘、副总经理、 董事、苏州光格科技股份有限公司董事会秘书兼任财务总监;2020 年 11 月至今 任苏州光格科技股份有限公司董事会秘书;2020 年 12 月至今任江苏日久光电股 份有限公司独立董事。 (二)独立性情况 报告期内,作为公司的独立董事,本人未在公司担任除独立董事以外的任何 职务,本人及直系亲属、主 ...